Global Neurovascular Devices Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
According to APO Research, The global Neurovascular Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Neurovascular Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Neurovascular Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Neurovascular Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Neurovascular Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Neurovascular Devices include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo, Penumbra, Microport Scientific Corporation, Abbott Vascular and W. L. Gore & Associates, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Neurovascular Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neurovascular Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Neurovascular Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurovascular Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Neurovascular Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Neurovascular Devices sales, projected growth trends, production technology, application and end-user industry.
Neurovascular Devices segment by Company
1. To analyze and research the global Neurovascular Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Neurovascular Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Neurovascular Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Neurovascular Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Neurovascular Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurovascular Devices industry.
Chapter 3: Detailed analysis of Neurovascular Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Neurovascular Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Neurovascular Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
According to APO Research, The global Neurovascular Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Neurovascular Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Neurovascular Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Neurovascular Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Neurovascular Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Neurovascular Devices include Stryker Corporation, Johnson & Johnson, Medtronic, Terumo, Penumbra, Microport Scientific Corporation, Abbott Vascular and W. L. Gore & Associates, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Neurovascular Devices, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Neurovascular Devices, also provides the sales of main regions and countries. Of the upcoming market potential for Neurovascular Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Neurovascular Devices sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Neurovascular Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Neurovascular Devices sales, projected growth trends, production technology, application and end-user industry.
Neurovascular Devices segment by Company
- Stryker Corporation
- Johnson & Johnson
- Medtronic
- Terumo
- Penumbra
- Microport Scientific Corporation
- Abbott Vascular
- W. L. Gore & Associates
- Aneurysm Coiling & Embolization Devices
- Cerebral Balloon Angioplasty & Stenting Systems
- Support Devices
- Neurothrombectomy Devices
- Hospitals
- Clinics
- Ambulatory Surgical Units
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Neurovascular Devices status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Neurovascular Devices market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Neurovascular Devices significant trends, drivers, influence factors in global and regions.
6. To analyze Neurovascular Devices competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Neurovascular Devices market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Neurovascular Devices industry.
Chapter 3: Detailed analysis of Neurovascular Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Neurovascular Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Neurovascular Devices in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Neurovascular Devices Sales Value (2019-2030)
1.2.2 Global Neurovascular Devices Sales Volume (2019-2030)
1.2.3 Global Neurovascular Devices Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 NEUROVASCULAR DEVICES MARKET DYNAMICS
2.1 Neurovascular Devices Industry Trends
2.2 Neurovascular Devices Industry Drivers
2.3 Neurovascular Devices Industry Opportunities and Challenges
2.4 Neurovascular Devices Industry Restraints
3 NEUROVASCULAR DEVICES MARKET BY COMPANY
3.1 Global Neurovascular Devices Company Revenue Ranking in 2023
3.2 Global Neurovascular Devices Revenue by Company (2019-2024)
3.3 Global Neurovascular Devices Sales Volume by Company (2019-2024)
3.4 Global Neurovascular Devices Average Price by Company (2019-2024)
3.5 Global Neurovascular Devices Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Neurovascular Devices Company Manufacturing Base & Headquarters
3.7 Global Neurovascular Devices Company, Product Type & Application
3.8 Global Neurovascular Devices Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Neurovascular Devices Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Neurovascular Devices Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 NEUROVASCULAR DEVICES MARKET BY TYPE
4.1 Neurovascular Devices Type Introduction
4.1.1 Aneurysm Coiling & Embolization Devices
4.1.2 Cerebral Balloon Angioplasty & Stenting Systems
4.1.3 Support Devices
4.1.4 Neurothrombectomy Devices
4.2 Global Neurovascular Devices Sales Volume by Type
4.2.1 Global Neurovascular Devices Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Neurovascular Devices Sales Volume by Type (2019-2030)
4.2.3 Global Neurovascular Devices Sales Volume Share by Type (2019-2030)
4.3 Global Neurovascular Devices Sales Value by Type
4.3.1 Global Neurovascular Devices Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Neurovascular Devices Sales Value by Type (2019-2030)
4.3.3 Global Neurovascular Devices Sales Value Share by Type (2019-2030)
5 NEUROVASCULAR DEVICES MARKET BY APPLICATION
5.1 Neurovascular Devices Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Ambulatory Surgical Units
5.2 Global Neurovascular Devices Sales Volume by Application
5.2.1 Global Neurovascular Devices Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Neurovascular Devices Sales Volume by Application (2019-2030)
5.2.3 Global Neurovascular Devices Sales Volume Share by Application (2019-2030)
5.3 Global Neurovascular Devices Sales Value by Application
5.3.1 Global Neurovascular Devices Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Neurovascular Devices Sales Value by Application (2019-2030)
5.3.3 Global Neurovascular Devices Sales Value Share by Application (2019-2030)
6 NEUROVASCULAR DEVICES MARKET BY REGION
6.1 Global Neurovascular Devices Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Neurovascular Devices Sales by Region (2019-2030)
6.2.1 Global Neurovascular Devices Sales by Region: 2019-2024
6.2.2 Global Neurovascular Devices Sales by Region (2025-2030)
6.3 Global Neurovascular Devices Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Neurovascular Devices Sales Value by Region (2019-2030)
6.4.1 Global Neurovascular Devices Sales Value by Region: 2019-2024
6.4.2 Global Neurovascular Devices Sales Value by Region (2025-2030)
6.5 Global Neurovascular Devices Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Neurovascular Devices Sales Value (2019-2030)
6.6.2 North America Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Neurovascular Devices Sales Value (2019-2030)
6.7.2 Europe Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Neurovascular Devices Sales Value (2019-2030)
6.8.2 Asia-Pacific Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Neurovascular Devices Sales Value (2019-2030)
6.9.2 Latin America Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Neurovascular Devices Sales Value (2019-2030)
6.10.2 Middle East & Africa Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
7 NEUROVASCULAR DEVICES MARKET BY COUNTRY
7.1 Global Neurovascular Devices Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Neurovascular Devices Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Neurovascular Devices Sales by Country (2019-2030)
7.3.1 Global Neurovascular Devices Sales by Country (2019-2024)
7.3.2 Global Neurovascular Devices Sales by Country (2025-2030)
7.4 Global Neurovascular Devices Sales Value by Country (2019-2030)
7.4.1 Global Neurovascular Devices Sales Value by Country (2019-2024)
7.4.2 Global Neurovascular Devices Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.5.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.6.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.7.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.8.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.9.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.10.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.11.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.12.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.13.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.14.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.15.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.16.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.17.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.18.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.19.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.20.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.21.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.22.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.23.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Stryker Corporation
8.1.1 Stryker Corporation Comapny Information
8.1.2 Stryker Corporation Business Overview
8.1.3 Stryker Corporation Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.1.4 Stryker Corporation Neurovascular Devices Product Portfolio
8.1.5 Stryker Corporation Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Neurovascular Devices Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Medtronic
8.3.1 Medtronic Comapny Information
8.3.2 Medtronic Business Overview
8.3.3 Medtronic Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.3.4 Medtronic Neurovascular Devices Product Portfolio
8.3.5 Medtronic Recent Developments
8.4 Terumo
8.4.1 Terumo Comapny Information
8.4.2 Terumo Business Overview
8.4.3 Terumo Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.4.4 Terumo Neurovascular Devices Product Portfolio
8.4.5 Terumo Recent Developments
8.5 Penumbra
8.5.1 Penumbra Comapny Information
8.5.2 Penumbra Business Overview
8.5.3 Penumbra Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.5.4 Penumbra Neurovascular Devices Product Portfolio
8.5.5 Penumbra Recent Developments
8.6 Microport Scientific Corporation
8.6.1 Microport Scientific Corporation Comapny Information
8.6.2 Microport Scientific Corporation Business Overview
8.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.6.4 Microport Scientific Corporation Neurovascular Devices Product Portfolio
8.6.5 Microport Scientific Corporation Recent Developments
8.7 Abbott Vascular
8.7.1 Abbott Vascular Comapny Information
8.7.2 Abbott Vascular Business Overview
8.7.3 Abbott Vascular Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.7.4 Abbott Vascular Neurovascular Devices Product Portfolio
8.7.5 Abbott Vascular Recent Developments
8.8 W. L. Gore & Associates
8.8.1 W. L. Gore & Associates Comapny Information
8.8.2 W. L. Gore & Associates Business Overview
8.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.8.4 W. L. Gore & Associates Neurovascular Devices Product Portfolio
8.8.5 W. L. Gore & Associates Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Neurovascular Devices Value Chain Analysis
9.1.1 Neurovascular Devices Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Neurovascular Devices Sales Mode & Process
9.2 Neurovascular Devices Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Neurovascular Devices Distributors
9.2.3 Neurovascular Devices Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Neurovascular Devices Sales Value (2019-2030)
1.2.2 Global Neurovascular Devices Sales Volume (2019-2030)
1.2.3 Global Neurovascular Devices Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 NEUROVASCULAR DEVICES MARKET DYNAMICS
2.1 Neurovascular Devices Industry Trends
2.2 Neurovascular Devices Industry Drivers
2.3 Neurovascular Devices Industry Opportunities and Challenges
2.4 Neurovascular Devices Industry Restraints
3 NEUROVASCULAR DEVICES MARKET BY COMPANY
3.1 Global Neurovascular Devices Company Revenue Ranking in 2023
3.2 Global Neurovascular Devices Revenue by Company (2019-2024)
3.3 Global Neurovascular Devices Sales Volume by Company (2019-2024)
3.4 Global Neurovascular Devices Average Price by Company (2019-2024)
3.5 Global Neurovascular Devices Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Neurovascular Devices Company Manufacturing Base & Headquarters
3.7 Global Neurovascular Devices Company, Product Type & Application
3.8 Global Neurovascular Devices Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Neurovascular Devices Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Neurovascular Devices Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 NEUROVASCULAR DEVICES MARKET BY TYPE
4.1 Neurovascular Devices Type Introduction
4.1.1 Aneurysm Coiling & Embolization Devices
4.1.2 Cerebral Balloon Angioplasty & Stenting Systems
4.1.3 Support Devices
4.1.4 Neurothrombectomy Devices
4.2 Global Neurovascular Devices Sales Volume by Type
4.2.1 Global Neurovascular Devices Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Neurovascular Devices Sales Volume by Type (2019-2030)
4.2.3 Global Neurovascular Devices Sales Volume Share by Type (2019-2030)
4.3 Global Neurovascular Devices Sales Value by Type
4.3.1 Global Neurovascular Devices Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Neurovascular Devices Sales Value by Type (2019-2030)
4.3.3 Global Neurovascular Devices Sales Value Share by Type (2019-2030)
5 NEUROVASCULAR DEVICES MARKET BY APPLICATION
5.1 Neurovascular Devices Application Introduction
5.1.1 Hospitals
5.1.2 Clinics
5.1.3 Ambulatory Surgical Units
5.2 Global Neurovascular Devices Sales Volume by Application
5.2.1 Global Neurovascular Devices Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Neurovascular Devices Sales Volume by Application (2019-2030)
5.2.3 Global Neurovascular Devices Sales Volume Share by Application (2019-2030)
5.3 Global Neurovascular Devices Sales Value by Application
5.3.1 Global Neurovascular Devices Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Neurovascular Devices Sales Value by Application (2019-2030)
5.3.3 Global Neurovascular Devices Sales Value Share by Application (2019-2030)
6 NEUROVASCULAR DEVICES MARKET BY REGION
6.1 Global Neurovascular Devices Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Neurovascular Devices Sales by Region (2019-2030)
6.2.1 Global Neurovascular Devices Sales by Region: 2019-2024
6.2.2 Global Neurovascular Devices Sales by Region (2025-2030)
6.3 Global Neurovascular Devices Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Neurovascular Devices Sales Value by Region (2019-2030)
6.4.1 Global Neurovascular Devices Sales Value by Region: 2019-2024
6.4.2 Global Neurovascular Devices Sales Value by Region (2025-2030)
6.5 Global Neurovascular Devices Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Neurovascular Devices Sales Value (2019-2030)
6.6.2 North America Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Neurovascular Devices Sales Value (2019-2030)
6.7.2 Europe Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Neurovascular Devices Sales Value (2019-2030)
6.8.2 Asia-Pacific Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Neurovascular Devices Sales Value (2019-2030)
6.9.2 Latin America Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Neurovascular Devices Sales Value (2019-2030)
6.10.2 Middle East & Africa Neurovascular Devices Sales Value Share by Country, 2023 VS 2030
7 NEUROVASCULAR DEVICES MARKET BY COUNTRY
7.1 Global Neurovascular Devices Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Neurovascular Devices Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Neurovascular Devices Sales by Country (2019-2030)
7.3.1 Global Neurovascular Devices Sales by Country (2019-2024)
7.3.2 Global Neurovascular Devices Sales by Country (2025-2030)
7.4 Global Neurovascular Devices Sales Value by Country (2019-2030)
7.4.1 Global Neurovascular Devices Sales Value by Country (2019-2024)
7.4.2 Global Neurovascular Devices Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.5.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.6.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.7.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.8.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.9.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.10.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.11.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.12.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.13.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.14.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.15.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.16.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.17.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.18.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.19.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.20.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.21.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.22.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Neurovascular Devices Sales Value Growth Rate (2019-2030)
7.23.2 Global Neurovascular Devices Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Neurovascular Devices Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Stryker Corporation
8.1.1 Stryker Corporation Comapny Information
8.1.2 Stryker Corporation Business Overview
8.1.3 Stryker Corporation Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.1.4 Stryker Corporation Neurovascular Devices Product Portfolio
8.1.5 Stryker Corporation Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.2.4 Johnson & Johnson Neurovascular Devices Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Medtronic
8.3.1 Medtronic Comapny Information
8.3.2 Medtronic Business Overview
8.3.3 Medtronic Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.3.4 Medtronic Neurovascular Devices Product Portfolio
8.3.5 Medtronic Recent Developments
8.4 Terumo
8.4.1 Terumo Comapny Information
8.4.2 Terumo Business Overview
8.4.3 Terumo Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.4.4 Terumo Neurovascular Devices Product Portfolio
8.4.5 Terumo Recent Developments
8.5 Penumbra
8.5.1 Penumbra Comapny Information
8.5.2 Penumbra Business Overview
8.5.3 Penumbra Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.5.4 Penumbra Neurovascular Devices Product Portfolio
8.5.5 Penumbra Recent Developments
8.6 Microport Scientific Corporation
8.6.1 Microport Scientific Corporation Comapny Information
8.6.2 Microport Scientific Corporation Business Overview
8.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.6.4 Microport Scientific Corporation Neurovascular Devices Product Portfolio
8.6.5 Microport Scientific Corporation Recent Developments
8.7 Abbott Vascular
8.7.1 Abbott Vascular Comapny Information
8.7.2 Abbott Vascular Business Overview
8.7.3 Abbott Vascular Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.7.4 Abbott Vascular Neurovascular Devices Product Portfolio
8.7.5 Abbott Vascular Recent Developments
8.8 W. L. Gore & Associates
8.8.1 W. L. Gore & Associates Comapny Information
8.8.2 W. L. Gore & Associates Business Overview
8.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Value and Gross Margin (2019-2024)
8.8.4 W. L. Gore & Associates Neurovascular Devices Product Portfolio
8.8.5 W. L. Gore & Associates Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Neurovascular Devices Value Chain Analysis
9.1.1 Neurovascular Devices Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Neurovascular Devices Sales Mode & Process
9.2 Neurovascular Devices Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Neurovascular Devices Distributors
9.2.3 Neurovascular Devices Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Neurovascular Devices Industry Trends
Table 2. Neurovascular Devices Industry Drivers
Table 3. Neurovascular Devices Industry Opportunities and Challenges
Table 4. Neurovascular Devices Industry Restraints
Table 5. Global Neurovascular Devices Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Neurovascular Devices Revenue Share by Company (2019-2024)
Table 7. Global Neurovascular Devices Sales Volume by Company (K Units) & (2019-2024)
Table 8. Global Neurovascular Devices Sales Volume Share by Company (2019-2024)
Table 9. Global Neurovascular Devices Average Price (USD/Unit) of Company (2019-2024)
Table 10. Global Neurovascular Devices Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Neurovascular Devices Key Company Manufacturing Base & Headquarters
Table 12. Global Neurovascular Devices Company, Product Type & Application
Table 13. Global Neurovascular Devices Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Neurovascular Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Aneurysm Coiling & Embolization Devices
Table 18. Major Companies of Cerebral Balloon Angioplasty & Stenting Systems
Table 19. Major Companies of Support Devices
Table 20. Major Companies of Neurothrombectomy Devices
Table 21. Global Neurovascular Devices Sales Volume by Type 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Neurovascular Devices Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Neurovascular Devices Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Neurovascular Devices Sales Volume Share by Type (2019-2024)
Table 25. Global Neurovascular Devices Sales Volume Share by Type (2025-2030)
Table 26. Global Neurovascular Devices Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Neurovascular Devices Sales Value by Type (2019-2024) & (US$ Million)
Table 28. Global Neurovascular Devices Sales Value by Type (2025-2030) & (US$ Million)
Table 29. Global Neurovascular Devices Sales Value Share by Type (2019-2024)
Table 30. Global Neurovascular Devices Sales Value Share by Type (2025-2030)
Table 31. Major Companies of Hospitals
Table 32. Major Companies of Clinics
Table 33. Major Companies of Ambulatory Surgical Units
Table 34. Global Neurovascular Devices Sales Volume by Application 2019 VS 2023 VS 2030 (K Units)
Table 35. Global Neurovascular Devices Sales Volume by Application (2019-2024) & (K Units)
Table 36. Global Neurovascular Devices Sales Volume by Application (2025-2030) & (K Units)
Table 37. Global Neurovascular Devices Sales Volume Share by Application (2019-2024)
Table 38. Global Neurovascular Devices Sales Volume Share by Application (2025-2030)
Table 39. Global Neurovascular Devices Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 40. Global Neurovascular Devices Sales Value by Application (2019-2024) & (US$ Million)
Table 41. Global Neurovascular Devices Sales Value by Application (2025-2030) & (US$ Million)
Table 42. Global Neurovascular Devices Sales Value Share by Application (2019-2024)
Table 43. Global Neurovascular Devices Sales Value Share by Application (2025-2030)
Table 44. Global Neurovascular Devices Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Table 45. Global Neurovascular Devices Sales by Region (2019-2024) & (K Units)
Table 46. Global Neurovascular Devices Sales Market Share by Region (2019-2024)
Table 47. Global Neurovascular Devices Sales by Region (2025-2030) & (K Units)
Table 48. Global Neurovascular Devices Sales Market Share by Region (2025-2030)
Table 49. Global Neurovascular Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 50. Global Neurovascular Devices Sales Value by Region (2019-2024) & (US$ Million)
Table 51. Global Neurovascular Devices Sales Value Share by Region (2019-2024)
Table 52. Global Neurovascular Devices Sales Value by Region (2025-2030) & (US$ Million)
Table 53. Global Neurovascular Devices Sales Value Share by Region (2025-2030)
Table 54. Global Neurovascular Devices Market Average Price (USD/Unit) by Region (2019-2024)
Table 55. Global Neurovascular Devices Market Average Price (USD/Unit) by Region (2025-2030)
Table 56. Global Neurovascular Devices Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Table 57. Global Neurovascular Devices Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. Global Neurovascular Devices Sales by Country (2019-2024) & (K Units)
Table 59. Global Neurovascular Devices Sales Market Share by Country (2019-2024)
Table 60. Global Neurovascular Devices Sales by Country (2025-2030) & (K Units)
Table 61. Global Neurovascular Devices Sales Market Share by Country (2025-2030)
Table 62. Global Neurovascular Devices Sales Value by Country (2019-2024) & (US$ Million)
Table 63. Global Neurovascular Devices Sales Value Market Share by Country (2019-2024)
Table 64. Global Neurovascular Devices Sales Value by Country (2025-2030) & (US$ Million)
Table 65. Global Neurovascular Devices Sales Value Market Share by Country (2025-2030)
Table 66. Stryker Corporation Company Information
Table 67. Stryker Corporation Business Overview
Table 68. Stryker Corporation Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Stryker Corporation Neurovascular Devices Product Portfolio
Table 70. Stryker Corporation Recent Development
Table 71. Johnson & Johnson Company Information
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Johnson & Johnson Neurovascular Devices Product Portfolio
Table 75. Johnson & Johnson Recent Development
Table 76. Medtronic Company Information
Table 77. Medtronic Business Overview
Table 78. Medtronic Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Medtronic Neurovascular Devices Product Portfolio
Table 80. Medtronic Recent Development
Table 81. Terumo Company Information
Table 82. Terumo Business Overview
Table 83. Terumo Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Terumo Neurovascular Devices Product Portfolio
Table 85. Terumo Recent Development
Table 86. Penumbra Company Information
Table 87. Penumbra Business Overview
Table 88. Penumbra Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Penumbra Neurovascular Devices Product Portfolio
Table 90. Penumbra Recent Development
Table 91. Microport Scientific Corporation Company Information
Table 92. Microport Scientific Corporation Business Overview
Table 93. Microport Scientific Corporation Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Microport Scientific Corporation Neurovascular Devices Product Portfolio
Table 95. Microport Scientific Corporation Recent Development
Table 96. Abbott Vascular Company Information
Table 97. Abbott Vascular Business Overview
Table 98. Abbott Vascular Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Abbott Vascular Neurovascular Devices Product Portfolio
Table 100. Abbott Vascular Recent Development
Table 101. W. L. Gore & Associates Company Information
Table 102. W. L. Gore & Associates Business Overview
Table 103. W. L. Gore & Associates Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. W. L. Gore & Associates Neurovascular Devices Product Portfolio
Table 105. W. L. Gore & Associates Recent Development
Table 106. Key Raw Materials
Table 107. Raw Materials Key Suppliers
Table 108. Neurovascular Devices Distributors List
Table 109. Neurovascular Devices Customers List
Table 110. Research Programs/Design for This Report
Table 111. Authors List of This Report
Table 112. Secondary Sources
Table 113. Primary Sources
Table 1. Neurovascular Devices Industry Trends
Table 2. Neurovascular Devices Industry Drivers
Table 3. Neurovascular Devices Industry Opportunities and Challenges
Table 4. Neurovascular Devices Industry Restraints
Table 5. Global Neurovascular Devices Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Neurovascular Devices Revenue Share by Company (2019-2024)
Table 7. Global Neurovascular Devices Sales Volume by Company (K Units) & (2019-2024)
Table 8. Global Neurovascular Devices Sales Volume Share by Company (2019-2024)
Table 9. Global Neurovascular Devices Average Price (USD/Unit) of Company (2019-2024)
Table 10. Global Neurovascular Devices Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Neurovascular Devices Key Company Manufacturing Base & Headquarters
Table 12. Global Neurovascular Devices Company, Product Type & Application
Table 13. Global Neurovascular Devices Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Neurovascular Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of Aneurysm Coiling & Embolization Devices
Table 18. Major Companies of Cerebral Balloon Angioplasty & Stenting Systems
Table 19. Major Companies of Support Devices
Table 20. Major Companies of Neurothrombectomy Devices
Table 21. Global Neurovascular Devices Sales Volume by Type 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Neurovascular Devices Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Neurovascular Devices Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Neurovascular Devices Sales Volume Share by Type (2019-2024)
Table 25. Global Neurovascular Devices Sales Volume Share by Type (2025-2030)
Table 26. Global Neurovascular Devices Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Neurovascular Devices Sales Value by Type (2019-2024) & (US$ Million)
Table 28. Global Neurovascular Devices Sales Value by Type (2025-2030) & (US$ Million)
Table 29. Global Neurovascular Devices Sales Value Share by Type (2019-2024)
Table 30. Global Neurovascular Devices Sales Value Share by Type (2025-2030)
Table 31. Major Companies of Hospitals
Table 32. Major Companies of Clinics
Table 33. Major Companies of Ambulatory Surgical Units
Table 34. Global Neurovascular Devices Sales Volume by Application 2019 VS 2023 VS 2030 (K Units)
Table 35. Global Neurovascular Devices Sales Volume by Application (2019-2024) & (K Units)
Table 36. Global Neurovascular Devices Sales Volume by Application (2025-2030) & (K Units)
Table 37. Global Neurovascular Devices Sales Volume Share by Application (2019-2024)
Table 38. Global Neurovascular Devices Sales Volume Share by Application (2025-2030)
Table 39. Global Neurovascular Devices Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 40. Global Neurovascular Devices Sales Value by Application (2019-2024) & (US$ Million)
Table 41. Global Neurovascular Devices Sales Value by Application (2025-2030) & (US$ Million)
Table 42. Global Neurovascular Devices Sales Value Share by Application (2019-2024)
Table 43. Global Neurovascular Devices Sales Value Share by Application (2025-2030)
Table 44. Global Neurovascular Devices Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Table 45. Global Neurovascular Devices Sales by Region (2019-2024) & (K Units)
Table 46. Global Neurovascular Devices Sales Market Share by Region (2019-2024)
Table 47. Global Neurovascular Devices Sales by Region (2025-2030) & (K Units)
Table 48. Global Neurovascular Devices Sales Market Share by Region (2025-2030)
Table 49. Global Neurovascular Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 50. Global Neurovascular Devices Sales Value by Region (2019-2024) & (US$ Million)
Table 51. Global Neurovascular Devices Sales Value Share by Region (2019-2024)
Table 52. Global Neurovascular Devices Sales Value by Region (2025-2030) & (US$ Million)
Table 53. Global Neurovascular Devices Sales Value Share by Region (2025-2030)
Table 54. Global Neurovascular Devices Market Average Price (USD/Unit) by Region (2019-2024)
Table 55. Global Neurovascular Devices Market Average Price (USD/Unit) by Region (2025-2030)
Table 56. Global Neurovascular Devices Sales by Country: 2019 VS 2023 VS 2030 (K Units)
Table 57. Global Neurovascular Devices Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. Global Neurovascular Devices Sales by Country (2019-2024) & (K Units)
Table 59. Global Neurovascular Devices Sales Market Share by Country (2019-2024)
Table 60. Global Neurovascular Devices Sales by Country (2025-2030) & (K Units)
Table 61. Global Neurovascular Devices Sales Market Share by Country (2025-2030)
Table 62. Global Neurovascular Devices Sales Value by Country (2019-2024) & (US$ Million)
Table 63. Global Neurovascular Devices Sales Value Market Share by Country (2019-2024)
Table 64. Global Neurovascular Devices Sales Value by Country (2025-2030) & (US$ Million)
Table 65. Global Neurovascular Devices Sales Value Market Share by Country (2025-2030)
Table 66. Stryker Corporation Company Information
Table 67. Stryker Corporation Business Overview
Table 68. Stryker Corporation Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Stryker Corporation Neurovascular Devices Product Portfolio
Table 70. Stryker Corporation Recent Development
Table 71. Johnson & Johnson Company Information
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Johnson & Johnson Neurovascular Devices Product Portfolio
Table 75. Johnson & Johnson Recent Development
Table 76. Medtronic Company Information
Table 77. Medtronic Business Overview
Table 78. Medtronic Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Medtronic Neurovascular Devices Product Portfolio
Table 80. Medtronic Recent Development
Table 81. Terumo Company Information
Table 82. Terumo Business Overview
Table 83. Terumo Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Terumo Neurovascular Devices Product Portfolio
Table 85. Terumo Recent Development
Table 86. Penumbra Company Information
Table 87. Penumbra Business Overview
Table 88. Penumbra Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Penumbra Neurovascular Devices Product Portfolio
Table 90. Penumbra Recent Development
Table 91. Microport Scientific Corporation Company Information
Table 92. Microport Scientific Corporation Business Overview
Table 93. Microport Scientific Corporation Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Microport Scientific Corporation Neurovascular Devices Product Portfolio
Table 95. Microport Scientific Corporation Recent Development
Table 96. Abbott Vascular Company Information
Table 97. Abbott Vascular Business Overview
Table 98. Abbott Vascular Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Abbott Vascular Neurovascular Devices Product Portfolio
Table 100. Abbott Vascular Recent Development
Table 101. W. L. Gore & Associates Company Information
Table 102. W. L. Gore & Associates Business Overview
Table 103. W. L. Gore & Associates Neurovascular Devices Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. W. L. Gore & Associates Neurovascular Devices Product Portfolio
Table 105. W. L. Gore & Associates Recent Development
Table 106. Key Raw Materials
Table 107. Raw Materials Key Suppliers
Table 108. Neurovascular Devices Distributors List
Table 109. Neurovascular Devices Customers List
Table 110. Research Programs/Design for This Report
Table 111. Authors List of This Report
Table 112. Secondary Sources
Table 113. Primary Sources
LIST OF FIGURES
Figure 1. Neurovascular Devices Product Picture
Figure 2. Global Neurovascular Devices Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Neurovascular Devices Sales (2019-2030) & (K Units)
Figure 5. Global Neurovascular Devices Sales Average Price (USD/Unit) & (2019-2030)
Figure 6. Global Neurovascular Devices Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Aneurysm Coiling & Embolization Devices Picture
Figure 10. Cerebral Balloon Angioplasty & Stenting Systems Picture
Figure 11. Support Devices Picture
Figure 12. Neurothrombectomy Devices Picture
Figure 13. Global Neurovascular Devices Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 14. Global Neurovascular Devices Sales Volume Share 2019 VS 2023 VS 2030
Figure 15. Global Neurovascular Devices Sales Volume Share by Type (2019-2030)
Figure 16. Global Neurovascular Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Neurovascular Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 18. Global Neurovascular Devices Sales Value Share by Type (2019-2030)
Figure 19. Hospitals Picture
Figure 20. Clinics Picture
Figure 21. Ambulatory Surgical Units Picture
Figure 22. Global Neurovascular Devices Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Neurovascular Devices Sales Volume Share 2019 VS 2023 VS 2030
Figure 24. Global Neurovascular Devices Sales Volume Share by Application (2019-2030)
Figure 25. Global Neurovascular Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Neurovascular Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 27. Global Neurovascular Devices Sales Value Share by Application (2019-2030)
Figure 28. Global Neurovascular Devices Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 29. Global Neurovascular Devices Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. Global Neurovascular Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 31. Global Neurovascular Devices Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 32. North America Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 33. North America Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Europe Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 35. Europe Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Asia-Pacific Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Latin America Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 39. Latin America Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 40. Middle East & Africa Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 42. USA Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. USA Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. USA Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Canada Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Canada Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Canada Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Germany Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Germany Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Germany Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. France Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. France Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. France Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. U.K. Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.K. Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. U.K. Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Italy Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Italy Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Italy Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Netherlands Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Netherlands Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Netherlands Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. Nordic Countries Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. Nordic Countries Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. Nordic Countries Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. China Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. China Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. China Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. Japan Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. Japan Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. Japan Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. South Korea Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. South Korea Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. South Korea Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Southeast Asia Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Southeast Asia Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Southeast Asia Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. India Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. India Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. India Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Australia Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Australia Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Australia Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Mexico Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Mexico Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Mexico Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Brazil Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Brazil Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Brazil Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Turkey Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. Turkey Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. Turkey Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. Saudi Arabia Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 94. Saudi Arabia Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 95. Saudi Arabia Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 96. UAE Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 97. UAE Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 98. UAE Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 99. Neurovascular Devices Value Chain
Figure 100. Manufacturing Cost Structure
Figure 101. Neurovascular Devices Sales Mode & Process
Figure 102. Direct Comparison with Distribution Share
Figure 103. Distributors Profiles
Figure 104. Years Considered
Figure 105. Research Process
Figure 106. Key Executives Interviewed
Figure 1. Neurovascular Devices Product Picture
Figure 2. Global Neurovascular Devices Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Neurovascular Devices Sales (2019-2030) & (K Units)
Figure 5. Global Neurovascular Devices Sales Average Price (USD/Unit) & (2019-2030)
Figure 6. Global Neurovascular Devices Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. Aneurysm Coiling & Embolization Devices Picture
Figure 10. Cerebral Balloon Angioplasty & Stenting Systems Picture
Figure 11. Support Devices Picture
Figure 12. Neurothrombectomy Devices Picture
Figure 13. Global Neurovascular Devices Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 14. Global Neurovascular Devices Sales Volume Share 2019 VS 2023 VS 2030
Figure 15. Global Neurovascular Devices Sales Volume Share by Type (2019-2030)
Figure 16. Global Neurovascular Devices Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Neurovascular Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 18. Global Neurovascular Devices Sales Value Share by Type (2019-2030)
Figure 19. Hospitals Picture
Figure 20. Clinics Picture
Figure 21. Ambulatory Surgical Units Picture
Figure 22. Global Neurovascular Devices Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 23. Global Neurovascular Devices Sales Volume Share 2019 VS 2023 VS 2030
Figure 24. Global Neurovascular Devices Sales Volume Share by Application (2019-2030)
Figure 25. Global Neurovascular Devices Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 26. Global Neurovascular Devices Sales Value Share 2019 VS 2023 VS 2030
Figure 27. Global Neurovascular Devices Sales Value Share by Application (2019-2030)
Figure 28. Global Neurovascular Devices Sales by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 29. Global Neurovascular Devices Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 30. Global Neurovascular Devices Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 31. Global Neurovascular Devices Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 32. North America Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 33. North America Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Europe Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 35. Europe Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Asia-Pacific Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Latin America Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 39. Latin America Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 40. Middle East & Africa Neurovascular Devices Sales Value (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Neurovascular Devices Sales Value Share by Country (%), 2023 VS 2030
Figure 42. USA Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 43. USA Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 44. USA Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 45. Canada Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 46. Canada Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 47. Canada Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 48. Germany Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 49. Germany Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 50. Germany Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 51. France Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. France Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 53. France Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 54. U.K. Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.K. Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 56. U.K. Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 57. Italy Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 58. Italy Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 59. Italy Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 60. Netherlands Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Netherlands Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 62. Netherlands Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 63. Nordic Countries Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 64. Nordic Countries Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 65. Nordic Countries Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 66. China Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 67. China Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 68. China Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 69. Japan Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 70. Japan Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 71. Japan Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 72. South Korea Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 73. South Korea Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 74. South Korea Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 75. Southeast Asia Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. Southeast Asia Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 77. Southeast Asia Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 78. India Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. India Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 80. India Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 81. Australia Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 82. Australia Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 83. Australia Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 84. Mexico Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 85. Mexico Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 86. Mexico Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 87. Brazil Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 88. Brazil Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 89. Brazil Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 90. Turkey Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 91. Turkey Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 92. Turkey Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 93. Saudi Arabia Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 94. Saudi Arabia Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 95. Saudi Arabia Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 96. UAE Neurovascular Devices Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 97. UAE Neurovascular Devices Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 98. UAE Neurovascular Devices Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 99. Neurovascular Devices Value Chain
Figure 100. Manufacturing Cost Structure
Figure 101. Neurovascular Devices Sales Mode & Process
Figure 102. Direct Comparison with Distribution Share
Figure 103. Distributors Profiles
Figure 104. Years Considered
Figure 105. Research Process
Figure 106. Key Executives Interviewed
